Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAtara Biotherapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$10.58 | -$2.25 | -$6.42 |
| Q2 2024 | 1 | -$3.69 | -$0.79 | -$2.24 |
| Q3 2024 | 1 | -$3.11 | -$0.66 | -$1.89 |
| Q4 2024 | 2 | -$3.14 | -$0.79 | -$1.86 |
| Q1 2025 | 2 | -$4.00 | $4.42 | $0.21 |
| Q2 2025 | 1 | $0.05 | $0.22 | $0.14 |
| Q3 2025 | 1 | -$3.82 | -$0.81 | -$2.32 |
| Q4 2025 | 1 | -$3.00 | -$0.64 | -$1.82 |
Atara Biotherapeutics, Inc. Earnings Date And Information
Atara Biotherapeutics, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-2.93 earnings per share for the quarter, topping analysts' consensus estimates of $-3.77 by $0.84. The company had revenue of 40.19 M for the quarter and had revenue of 8.57 M for the year. Atara Biotherapeutics, Inc. has generated $-65 earnings per share over the last year ($-65.18 diluted earnings per share) and currently has a price-to-earnings ratio of -0.1. Atara Biotherapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Atara Biotherapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$3.77 | -$2.93 | 0.84 | $28.66 M | $40.19 M |
| 08/12/2024 | Q2 2024 | -$1.25 | -$3.10 | -1.85 | $37.09 M | $28.64 M |
| 05/09/2024 | Q1 2024 | -$9.25 | -$5.65 | 3.6 | $27.36 M | |
| 03/28/2024 | Q4 2023 | -$13.98 | $4.25 M | |||
| 11/01/2023 | Q3 2023 | -$15.75 | -$16.40 | -0.65 | $5.09 M | $2.14 M |
| 08/08/2023 | Q2 2023 | -$16.25 | -$16.91 | -0.66 | $4.36 M | $957,000 |
| 05/08/2023 | Q1 2023 | -$10.00 | -$17.98 | -7.98 | $1.23 M | |
| 02/08/2023 | Q4 2022 | -$15.25 | -$18.07 | -2.82 | $221,000 | |
| 11/08/2022 | Q3 2022 | -$19.50 | -$20.53 | -1.03 | $5.13 M | $4.46 M |
| 08/08/2022 | Q2 2022 | -$22.75 | $4.54 | 27.29 | $6.84 M | $51.58 M |
| 05/05/2022 | Q1 2022 | -$24.50 | -$21.87 | 2.63 | $7.31 M | |
| 02/28/2022 | Q4 2021 | -$15.00 | -$23.96 | -8.96 | $7.55 M | |
| 11/04/2021 | Q3 2021 | -$23.00 | -$22.61 | 0.39 | $4.55 M | $5.37 M |
| 08/09/2021 | Q2 2021 | -$22.00 | -$22.73 | -0.73 | $4.95 M | $3.87 M |
| 05/04/2021 | Q1 2021 | -$23.25 | -$21.41 | 1.84 | $3.55 M | |
| 03/01/2021 | Q4 2020 | -$18.25 | -$23.83 | -5.58 | $358.19 M | |
| 11/09/2020 | Q3 2020 | -$27.50 | -$22.90 | 4.6 | $0 | |
| 08/05/2020 | Q2 2020 | -$30.25 | -$28.49 | 1.76 | $0 | |
| 05/06/2020 | Q1 2020 | -$34.00 | -$30.02 | 3.98 | $0 | |
| 02/27/2020 | Q4 2019 | -$32.50 | -$34.03 | -1.53 | $0 |
Atara Biotherapeutics, Inc. Earnings: FAQ's
When is Atara Biotherapeutics, Inc.'s earnings date?
Atara Biotherapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
Did Atara Biotherapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Atara Biotherapeutics, Inc. (:ATRA) reported $-2.93 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.77 by $0.84.
How can I listen to Atara Biotherapeutics, Inc.'s earnings conference
call?
The conference call for Atara Biotherapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Atara Biotherapeutics, Inc.'s conference call transcript?
The conference call transcript for Atara Biotherapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Atara Biotherapeutics, Inc. generate each year?
Atara Biotherapeutics, Inc. (:ATRA) has a recorded annual revenue of $8.57 M.
How much profit does Atara Biotherapeutics, Inc. generate each year?
Atara Biotherapeutics, Inc. (:ATRA) has a recorded net income of $8.57 M. Atara Biotherapeutics, Inc. has generated $-65.18 earnings per share over the last four quarters.
What is Atara Biotherapeutics, Inc.'s price-to-earnings ratio?
Atara Biotherapeutics, Inc. (:ATRA) has a price-to-earnings ratio of -0.1 and price/earnings-to-growth ratio is -0.